Aachen, Germany – 7 July 2022 – Grünenthal, Uniklinik RWTH Aachen and RWTH Aachen University announced a collaboration to advance the development of next-generation pain medicines. The collaboration involves the institutes of Dr Angelika Lampert, Professor of Physiology at the ...
Aachen, Germany, and Raleigh, North Carolina – USA, 29 March 2022 – Grünenthal and NovaQuest announced today that they have entered into an agreement to advance the global clinical Phase III programme of Grünenthal’s asset resiniferatoxin (RTX). The investigational medicine ...
The National Physical Laboratory (NPL), today announces the selection of three innovation nodes in partnership with the University of Strathclyde, University of Surrey, and Cranfield University. These innovation nodes are being developed in partnership between NPL and the host organisations ...
New report presents neuroscientific findings on digital journeys and the power of emotional purchasing Barometer sees fashion sector setting standards high with average score of 80.7, driving demand for digital differentiation London UK; 21st March 2022: Delivery experience platform Sorted ...
Aachen, Germany, 7 March 2022 – Grünenthal, an international science-driven pharmaceutical company, announced that it has donated 400.000€ to the Red Cross to support humanitarian relief efforts in Ukraine and Eastern Europe. In addition, Grünenthal partners with Action Medeor and ...
A quantum photonics spin-out from the University of Sheffield lands seven-figure investment from a syndicate, led by High-Tech Gründerfonds, to develop next-generation networking with quantum security The investment comes along with funding from Innovate UK and brings Aegiq’s total funding ...
Institute assumes tasks of a WHO Collaborating Center (WHO-CC) Implementation Research – Kontrast Personalberatung assists in filling position The research institute from Hamburg will establish the department of implementation research and, with the new professorship of tropical medicine, set up ...
Aachen, Germany, 29 September 2021 – Today, Grünenthal announced that the first participants have been enrolled in a randomised, placebo- and active-controlled clinical trial for its peripherally restricted Nociceptin/Orphanin FQ peptide receptor (NOP) agonist. The compound is being developed to ...
The study AV001 aims to include the treatment of post-surgical neuropathic pain (PSNP) in the U.S. label. QUTENZA® is currently approved for use in adults in the treatment of neuropathic pain associated with postherpetic neuralgia and for the treatment of ...
London, 15 July 2021 The Alan Turing Institute, the UK’s national institute for data science and artificial intelligence, is inviting submissions from around the world to its first (virtual) conference on trustworthy digital identity, 13 September 2021. Staged to bring ...